Outbreak of Paralytic Poliomyelitis in a Highly Immunized Population in Jordan

Size: px
Start display at page:

Download "Outbreak of Paralytic Poliomyelitis in a Highly Immunized Population in Jordan"

Transcription

1 862 Outbreak f Paralytic Plimyelitis in a Highly Immunized Ppulatin in Jrdan Mary R. Reichler, Adnan Abbas,* Sa'ad Kharabsheh, Azmi Mahafzah, James P. Alexander, Jr., Philip Rhdes, Samir Fauri, Haider Otum, Samir Blch, Mazen Abdel Majid, Mick Mulders, Rafi Aslanian, Harry F. Hull, Mark A. Pallansch, and Peter A. Patriarca* Pli Eradicatin Activity and Data Management Branch, Natinal Immunizatin Prgram, and Entervirus Branch, Natinal Center fr Infectius Diseases, Centers fr Disease Cntrl and Preventin, Atlanta, Gergia; Disease Preventin and Cntrl Directrate and Jrdan Vaccine Institute, Ministry fhealth, Department flabratry Medicine, Jrdan University Hspital, and Department fpediatrics, Al Bashir Hspital, Amman, Jrdan; Labratry f Virlgy, Natinal Institute fr Public Health and Envirnmental Prtectin (RIVM), Bilthven, Netherlands; Eliminatin and Eradicatin fdiseases, Eastern Mediterranean Reginal Office, Wrld Health Organizatin, Alexandria, Egypt; Glbal Prgramme fr Vaccines and Immunizatin, Wrld Health Organizatin, Geneva, Switzerland Between Nvember 1991 and March 1992, 37 cases f paralytic plimyelitis ccurred in Jrdan, where nne had been reprted since Of these, 17 (%) f 34 patients had received at least three dses f ral plivirus vaccine (OPV3). The first and 2 subsequent case-patients were children f Pakistani migrant wrkers, and the first 8 and a ttal f 27 (7%) case-patients resided in r near the Jrdan Valley. A serepidemilgic study f 987 children in all regins f Jrdan was perfrmed t assess OPV3 cverage and immune respnse t OPV. Althugh OPV3 cverage by 12 mnths f age was high (96%) in the general ppulatin, cverage was lwer amng Pakistani (21%), Beduin (63%), and Gypsy (9%) children (P <.1). Serprevalences fr plivirus type 3 were 71% in the Jrdan Valley versus 81% in ther regins after 3 dses f OPV (P <.6) and 77% in the Jrdan Valley versus 98% in ther regins after dses f OPV (P <.1). This utbreak demnstrates the imprtance f achieving high serimmunity t infectin in all gegraphic areas t prevent the reintrductin and spread f imprted strains f wild plivirus. Paralytic plimyelitis was rapidly eliminated frm industrialized cuntries and its incidence markedly reduced wrldwide nce high cverage with at least three dses f the live attenuated ral plivirusvaccine (OPV) was achieved [1, 2]. Despite high cverage with OPV, sme cuntries experience utbreaks f paralytic plimyelitis caused by imprted strains f wild plivirus several years after indigenus wild plivirus transmissin has ceased [3-]. Strategies t prevent the reintrductin and spread fwild plivirus in pli-free areas are essential t achieve the gal f glbal eradicatin f paralytic plimyelitis, planned fr the year 2. We reprt the results f ur investigatin f an unusual epidemic f paralytic plimyelitis in Jrdan, a cuntry with high OPV cverage and n reprted plimyelitis cases fr Presented in part: 32nd Interscience Cnference n Antimicrbial Agents and Chemtherapy, Anaheim, Califrnia, Octber 1992 (abstract 1723); 34th Interscience Cnference n Antimicrbial Agents and Chemtherapy, Orland, Flrida, Octber 1994 (abstracts J93 and J9). Infrmed cnsent was btained frm the parents f children enrlled in these studies. Reprints r crrespndence: Dr. Mary R. Reichler, Mailstp E-, NIP, CDC, 16 Cliftn Rd., Atlanta, GA * Present affiliatins: Department f Cmmunity Medicine, Jrdan University, Amman, Jrdan (A.A.); Center fr Bilgics Evaluatin and Research, Fd and Drug Administratin, Bethesda, Maryland (P.P.). The Jurnal f Infectius Diseases 1997; 17(8uppl 1): by The University f Chicag. All rights reserved /97/781-12$1. > 3 years. The epidemic ccurred during the winter (the lw seasn fr wild plivirus transmissin) and remained lcalized t ne regin f the cuntry fr several mnths. Large utbreaks fparalytic plimyelitis are infrequent in highly immunized ppulatins, generally ccur during the summer mnths, and are usually assciated with rapid and wide gegraphic spread. In this reprt, we examine the relatinship f unimmunized subppulatins, reginal differences in immune respnse t vaccine, vaccinatin timing, and ther factrs t the risk f epidemic paralytic plimyelitis in a ppulatin with high verall vaccinatin cverage. Backgrund Children in Jrdan receive dses f OPV at 3, 4, -6, and 18 mnths f age. Estimated vaccinatin cverage with three dses f OPV (OPV3) by 1 year f age in Jrdan has been > 8% since 1986 and was estimated in 199 by cluster survey methdlgy t be 92%. Prir t the current utbreak, n cases f plimyelitis had been reprted in Jrdan since mid Althugh Jrdanians cmprise >9% fthe ttal ppulatin in all areas f Jrdan, there are a number f distinct subppulatins: (1) migratry Beduin tribes, fund thrughut Jrdan; (2) migratry agricultural wrkers frm Pakistan, residing in the suthern Jrdan Valley (Octber-April) and rural areas f Amman gvernrate (May-September); and (3) Gypsies, living in and near the Jrdan Valley (Octber-April) and in nrth- Dwnladed frm by guest n 27 December 218

2 JID 1997; 17 (Suppl 1) Pli Outbreak in Jrdan S63 em Jrdan (May-September). In additin, during the 1991 Gulf War..., nn-jrdanians sught temprary refuge in Jrdan and...3, Jrdanians living in Kuwait returned t Jrdan and were resettled thrughut the cuntry. Methds Case ascertainment. All hspitals and health centers in Jrdan were infrmed abut the utbreak:and instructed t reprt all cases facute flaccid paralysis (whether r nt acute plimyelitis was suspected) t the Jrdan Ministry fhealth. All cases were investigated by an expert team and cnfirmed r discarded accrding t standard Wrld Health Organizatin criteria [6]. Virlgy. Stl specimens frm 16 case-patients were prcessed at the Jrdan Vaccine Institute in Amman and the Natinal Institute fr Public Health and Envirnmental Prtectin in Bilthven, Netherlands. Enterviruses were islated and identified as pliviruses r nnpli enterviruses, and intratypic differentiatin was perfrmed n plivirus islates using previusly described techniques [7]. T determine the rigin f the type 1 wild pliviruses linked t the Jrdan utbreak, we perfrmed partial genmic sequencing f 8 f 9 utbreak strains and cmpared data frm these strains with a database cntaining nucletide sequences f >2 type 1 wild pliviruses islated between 197 and 1992 frm the Middle East, Africa, Asia, Nrth America, and Suth America, using previusly described techniques [3, 8-1]. Serepidemilgic studies. T evaluate the gegraphic extent f spread f wild plivirus during the utbreak and t determine the immune state f children in different regins f Jrdan, we btained sera frm the fllwing grups f children in the furth mnth f the utbreak (February 1992), prir t the first natinwide mass campaign: (1) 428 cntrl children frm 12 twns in the Jrdan Valley (the regin with the highest paralytic attack rate), including children frm 6 twns with and 6 twns withut detected cases; (2) 43 cntrl children frm Safi (lcated in the Gre Valley [4 kilmeters suth f the Jrdan Valley], where n cases were detected); (3) 23 cntrl children frm the 8 gvernrates in Jrdan (Amman, n = 71; Irbid, n = 43; Zarka, n = 39; Balka, n = 14; Mafraq, n = 11; Karak, n = 9; Tafila, n = 9; and Ma'an, n = 7), excluding Jrdan Valley districts; (4) 12 Pakistani (n = 62), Beduin (n = 18), and Gypsy (n = 22) children living in r near the Jrdan Valley; and () 17 case-patients ~21 days after paralysis nset (11 wh had received three r mre dses f OPV [fully immunized] and 6 wh had received n OPV dses [unimmunized] r ne t tw OPV dses [partially immunized] at least 21 days prir t paralysis nset) (figure 1). Since expsure t wild plivirus type 1 had already ccurred in parts f Jrdan, we measured antibdy t plivirus type 3 t assess immune respnse t OPV at the time f the utbreak. T examine the immune state f children in different regins fjrdan fllwing tw natinwide mass campaigns, we btained sera 6 weeks after the secnd campaign (May 1992) frm 198 cntrl children frm all 8 gvernrates in Jrdan, all f whm had received bth mass campaign dses f OPV. T determine the immune state f children in different regins f Jrdan at baseline (in the absence f wild plivirus circulatin), we btained sera in December 1993 and January 1994 frm the fllwing grups f children brn after the utbreak: (1) 74 cntrl children frm 2 twns in the Jrdan Valley (38 frm Abu-Obeideh and 36 frm Almashara); (2) 4 cntrl children frm Safi; (3) 4 cntrl children frm Amman gvernrate; and (4) 4 cntrl children frm Zarka gvernrate (figure 1). All cntrl children frm twns in the Jrdan Valley and Safi were a cnvenience sample selected accrding t a histry (dcumented by vaccinatin card) f having received three r mre dses f OPV at least 21 days prir t serum cllectin and age mnths at the time f serum cllectin. All cntrl children frm Jrdan gvernrates were a cluster survey sample selected accrding t a histry (dcumented by vaccinatin card) f having received three OPV dses thrugh the rutine prgram at least 3 days prir t serum cllectin and age 7-12 mnths at the time f serum cllectin. Pakistani, Beduin, and Gypsy cntrl children represented all children 7-36 mnths f age in these subppulatins that culd be identified in r near the Jrdan Valley at the time the survey was cnducted. All 987 sera frm case-patients and cntrl children enrlled in the serepidemilgic studies were tested in triplicate with a mdified micrneutralizatin technique at the Centers fr Disease Cntrl and Preventin (CDC), in dilutins ranging frm 1/8 t [7]. Immunizatin cverage studies. Written, standardized questinnaires prviding immunizatin infrmatin (dcumented by vaccinatin card) were cmpleted at the time sera were cllected fr all 987 children enrlled in the serepidemilgic studies. Evaluatin fthe cld chain. During the utbreak (January and February 1992), 11 vaccinatin sites (the central stre at the Jrdan Vaccine Institute in Amman and 1 peripheral sites in the JrdanValley) were visited t bserve vaccine strage, handling, and administratin techniques and t review cld-chain maintenance recrds. Vaccine efficacy. Using a standard frmula [11], we estimated the efficacy f three r mre dses f OPV administeredthrughthe rutineprgram amng childrenin Jrdan at the time f the utbreak. Statistical analysis. Statistically significant differences in type-specific antibdy titers and vaccinatin timing amng the varius grups f children were assessed with a nnparametric test (Wilcxn rank sum test) using SAS (Cary, NC) sftware. Results Outbreak. Between Nvember 1991 and March 1992, 37 cases f paralytic plimyelitis ccurred in Jrdan (figure 2). Of these patients, 33 (89%) were <36 mnths f age (range, 1-18) and 17 (%) had received at least three dses fopv; (14%) case-patients died. Type 1 wild plivirus was islated frm 9 (6%) f 16 case-patient stl specimens. The first 8 and a ttal f 27 (7%) cases ccurred in the Jrdan Valley (n = 18) r neighbring districts (n = 9) (figure 2). Paralytic attack rates were 13/1 in the Jrdan Valley and./1 utside the Jrdan Valley. Althugh 33 (92%) case-patients were Jrdanian, the first and 2 subsequent case-patients were children f Pakistani migrantwrkers. In the Jrdan Valley, paralytic attack rates were 1111 amng Jrdanians and 86/1 amng Pakistanis. Dwnladed frm by guest n 27 December 218

3 S64 Reichler et al. JID 1997; 17 (Suppl 1) LakeTiberias Gulf f Aqaba Figure 1. Gre Valley Bdies f water e Jrdan Valley and Gre Valley Study sites 2 Km " I I I I i, 2 Miles Map f Jrdan shwing all 8 Jrdan gvernrates and serepidemilgic study sites in Jrdan Valley and Gre Valley. A dr-t-dr vaccinatin campaign targeting all children < years f age with OPV was cnducted in the Jrdan Valley between 29 January and 6 February 1992; estimated vaccinatin cverage was 9%. Since cases cntinued t ccur in February, tw natinwide mass vaccinatin campaigns were cnducted, the first frm 24 February t 2 March and the secnd frm 6 t 13 April; estimated cverage fr bth natinwide campaigns was >9%. Althugh 4 cases ccurred in the 3-week perid fllwing the first natinwide vaccinatin campaign, nne ccurred fllwing the secnd campaign (figure 2). N further labratry-cnfirmed cases f plimyelitis have been reprted in Jrdan thrugh mid Virlgy. Type 1 wild plivirus was islated frm 9 (6%) f 16 case-patient stl specimens. All 8 utbreak islates analyzed by partial genmic sequencing were clsely related t ne anther (98% similarity f the VP1I2A regin), suggesting a recent cmmn rigin. The Jrdan islates were gentypically distinct frm prir wild type 1 pliviruses frm Israel (1988, 7% similarity) and mst ther cuntries in the Middle East but matched islates frm the utbreak in Oman (9% similarity) and a 1992 islate frm Pakistan (98% similarity) [9, 1]. Gegraphic extent fspread fwild plivirus during the utbreak. Vaccinated and unvaccinated case-patients, cntrl children frm twns in the Jrdan Valley with and withut cases, Pakistani cntrl children, and Beduin cntrl children wh had bld samples drawn during the utbreak all had similar type 1 neutralizing antibdy prfiles, suggesting that widespread expsure t wild plivirustype 1 ccurred in the JrdanValley during the utbreak (figure 3). Althugh serprevalences t plivirus type 1 were similar fr Jrdan Valley cntrls and nn-jrdan Valley gvernratecntrls wh had bld samples drawn during the utbreak(94% and 97%, respectively),titerswere significantly higher amng Jrdan Valley cntrls (gemetric mean titers f 898 vs. 616 [P <.], respectively), suggesting that expsure t wild plivirus was greater inside than utside the Jrdan Valley (figure 3). Dwnladed frm by guest n 27 December 218

4 JID 1997;17 (Supp11) Pli Outbreak in Jrdan S , N=37 - (I) <V (I) «S U- ~ <V. E:::J Z DOutside Jrdan Valley ffiilll Near Jrdan Valley In Jrdan Valley Oct Nv Dec Jan Feb Time (Weeks) - ~ r-- - r-- I I I I March April 1992 Figure 2. Cases f paralytic plimyelitis in Jrdan by gegraphic regin and week f nset. Of 37 cases, first 8 and ttal f 27 (7%) ccurred in Jrdan Valley (N; n = 18) r neighbring districts (n = 9). Arrws indicate timing f 4 mass vaccinatin campaigns, 2 limited t Jrdan Valley and 2 cnducted natinwide. Whereas cases cntinued t ccur fllwing first Jrdan Valley mass vaccinatin campaign, very few cases ccurred fllwing first natinwide campaign. Figure 4 presents the neutralizing antibdy prfiles fr children in selected twns inside and utside the Jrdan Valley wh had bld samples drawn during (figure 4A) versus after (figure 4B) the utbreak. Titers were significantly lwer in Jrdan Valley cntrls wh were brn and had bld samples drawn after the utbreak than in thse wh had bld samples drawn during the utbreak. Titers were als cnsistently lwer amng cntrls utside the Jrdan Valley wh were brn and had bld samples drawn after the utbreak cmpared with thse wh had bld samples drawn during the utbreak, suggesting that wild plivirus type 1 had already spread t at least sme areas utside the Jrdan Valley prir t the first natinwide mass campaign. Immune state f children in different regins f Jrdan. As illustrated in figure, the immune respnse t OPV was cnsistently lwer amng cntrl children in the Jrdan Valley than amng thse in ther regins f Jrdan. Serprevalence rates after three dses f OPV fr plivirus type 3 were 71% in the Jrdan Valley versus 81% (range, 64%-1%) amng gvernrate cntrls in ther regins (P <.6). Serprevalence rates after five dses f OPV fr plivirus type 3 were 77% in the Jrdan Valley versus 98% (range, 92%-1%) in ther regins (P <.1). Regins with higher paralytic attack rates were mre likely t have lwer serprevalence rates fr plivirus type 3 after three and five dses f OPV (figure ). In additin, the increase in serprevalence rates after five versus three dses f OPV fr plivirus type 3 was significantly smaller in the Jrdan Valley cmpared with ther regins (6% vs. 17%, respectively; P <.1). Immunizatin cverage studies. There was n assciatinbetween paralytic attack rate and OPV vaccinatin cverage, which ranged frm 96% t 1% by regin. Althugh survey children in the general ppulatin in the Jrdan Valley were selected n the basis f having received at least three dses f OPV, this is unlikely t represent a significant bias tward higher cverage estimates in this regin, since very few partially immunized r unimmunized children were identified during the survey. Figure 6 presents the timing f OPV receipt amng cntrls in the general ppulatin and Pakistani, Gypsy, and Beduin subppulatins in the Jrdan Valley. Althugh OPV3 cverage by 12 mnths f age was high amng children in the general ppulatin residing in the Jrdan Valley (96%), cverage was lwer amng Pakistani (21%), Beduin (63%), and Gypsy (9%) children (P <.1, cmparing general ppulatin and Pakistani children, general ppulatin and Beduin children, and general ppulatin and Gypsy children). Delays in cmpleting OPV3 ccurred in all grups in the Jrdan Valley surveyed: Only 71% f general ppulatin, 37% f Beduin, 3% fpakistani, and n Gypsy children had received OPV3 n schedule, by 6 mnths f age (figure 6). Althugh cverage at 12 mnths f age was similar fr children in the general ppulatin residing inside and utside the Jrdan Valley (96% vs. 1%, respectively), vaccinatin de- Dwnladed frm by guest n 27 December 218

5 S66 Reichler et al. lid 1997; 17 (Suppl 1) 7 Cases 6 (n=17) <8 8 Inside Jrdan Valley 1 twnswith cases (n=217) < >124 Inside Jrdan Valley 1 twns withut cases (n=211) < >124 II~Opv Titer 3 Pakistani 2 (n=62) <3PV < >124 Beduin (n=18) < >124 Outside Jrdan Valley (n=23) < >124 Figure 3. Serprevalence f neutralizing antibdy t plivirus type 1 amng case-patients and cntrls during utbreak ftype 1 paralytic plimyelitis in Jrdan. Vaccinated and unvaccinated case-patients, cntrl children inside and utside Jrdan Valley, and Pakistani and Beduin cntrl children wh had bld samples drawn during utbreak all had similar type 1 neutralizing antibdy prfiles. Dwnladed frm by guest n 27 December 218 lays were significantly greater amng children inside the Jrdan Valley (71% inside vs. 87% utside had received OPV3 by 6 mnths f age; P <.1) (data nt shwn). Regins in Jrdan with higher paralytic attack rates tended t have greater delays in cmpleting OPV3 (data nt shwn) Evaluatin fthe cld chain. N abnrmalities in vaccine strage r handling were nted in the central stre in Amman r in peripheral sites in the Jrdan Valley. Vaccine efficacy. Vaccine efficacy was estimated t be 96% verall in Jrdan, with separate estimates f 94% inside and 98% utside the Jrdan Valley. Discussin The plimyelitis utbreak in Jrdan ccurred fllwing imprtatin f wild plivirus int an area that had

6 JID 1997;17 (Suppll) Pli Outbreakin Jrdan Almashara A Almashara B (n=34) 1 1 (n=36) < >124 < > Abu Obeideh A Abu Obeideh B 2 (n=34) 2 (n=38) , CD ;; > c..., Amman A Amman B.- 2 < < ~ (n=71) (n=4) tn 2 2 ( , 1 C e... < > Zarka A Zarka B Z 1 (n=39) 1 (n=4) < < >124 < > Safi A 3 Safi B 2 (n=43) 2 (n=4) Dwnladed frm by guest n 27 December 218 < Titer < Figure 4. Serprevalence f neutralizing antibdy t plivirus type 1 amng cntrls frm selected twns inside and utside Jrdan Valley wh had bld samples drawn during (A) vs. thse wh were brn and had bld samples drawn after (B) utbreak f type 1 paralytic plimyelitis. Titers were cnsistently lwer amng cntrls inside and utside Jrdan Valley wh were brn and had bld samples drawn after utbreak cmpared with thse wh had bld samples drawn during utbreak.

7 S68 Reichler et al. JID 1997;17 (Suppll) :.p > 'en a. l- 4 (I) 3 C:~ ~ - /~...- <, '------r---r ~ lj~ ''3-~ ~flj. ~~*'3-3 dses f OPV dses f OPV (I) l- c 9 ~ LO v 7 c: l- :Q 6 :E 4 3 s ::: Figure. Prprtin f children with neutralizing antibdies t plivirus type 3 after 3 and dses f ral plivirus vaccine (OPY) and attack rates fparalytic plimyelitis by regin in Jrdan. Serprevalence rates after 3 dses f OPY fr plivirus type 3 were 71% in Jrdan Valley vs. 81% (range, 64%-1%) amng cntrls in ther regins (P <.6). Serprevalence rates after dses f OPV fr plivirus type 3 were 77% in Jrdan Valley vs. 98% (range, 92%-1%) in ther regins (P <.1). Statistical cmparisns were made with Wilcxn rank sum tests using SAS (Cary, NC) sftware. been pli-free fr several years. A gradual build-up fsusceptibles likely ccurs even in a highly immunized ppulatin nce endemic wild plivirus transmissin has ceased. Despite this, utbreaks rarely ccur if high levels f vaccinatin cverage are maintained. Our investigatin identified several factrs that greatly increased the number f susceptibles in the Jrdan Valley, thus cntributing t the utbreak. While cverage with at least three dses f OPV was very high amng children in the general ppulatin in all areas f Jrdan at the time fthe utbreak, there were 3 separate migratry subppulatins in the Jrdan Valley whse vaccinatin levels were cnsiderably lwer: children f Pakistani migrant wrkers, Gypsies, and Beduins. The initial case in the utbreak ccurred in a Pakistani child, and the attack rate in this subppulatin was 8-fld higher than amng children in the general ppulatin in the Jrdan Valley. The ptential fr wild plivirus transmissin t be sustained within pckets f unvaccinated children with subsequent spread t fully vaccinated children is well established [12, 13]. Thus, the intrductin and spread f wild plivirus by unimmunized migratry grups likely cntributed t infectin in the highly immunized general ppulatin in Jrdan. Althugh cverage with at least three dses f OPV by 12 mnths f age was high, fewer than three-quarters f children in the general ppulatin in the Jrdan Valley had received these dses n schedule, by 6 mnths f age. Furthermre, even greater delays in receipt f OPV dses ccurred fr Pakistani, Gypsy, and Beduin children. Thus, delays in cmpleting the OPV schedule amng children in the Jrdan Valley substantially increased the pl f unvaccinated children susceptible t plivirus infectin, likely increasing transmissin. Achieving high cverage with at least three dses f OPV in a timely fashin is imprtant t prvide sufficient ppulatin immunity t stp transmissin if reintrductin f wild plivirus ccurs. Reginal differences in antibdy respnses t OPV were present in Jrdan at the time f the utbreak despite high cverage with three dses f OPV in all regins. In the Jrdan Valley, serprevalence rates t plivirus type 3 after three and five dses f OPV were significantly lwer than in ther regins f the cuntry. Thus, subptimal immune respnse t as many as five dses f OPV amng children in the general ppulatin in the Jrdan Valley prduced a gap in immunity that als cntributed t spread f an imprted wild plivirus strain during the utbreak. Reginal variatin in immune respnse t OPV has als been nted in Oman, where utbreaks due t imprted strains fwild plivirus have been a recurrent prblem [3, 14]. Althugh risk factrs fr subptimal immune respnse t OPV culd nt be evaluated in the current study, factrs assciated with lw serprevalence in ther studies include residence in trpical and subtrpical areas; lw sciecnmic status; and diarrhea, nnpli entervirus infectin, r ther enteric Dwnladed frm by guest n 27 December 218

8 JID 1997;17 (Suppl 1) Pli Outbreakin Jrdan S69 1, Figure 6. Cumulative cverage with at least 3 dses f ral plivirus vaccine (OPV3) by mnth f age amng cntrls in general ppulatin and Pakistani, Gypsy, and Beduin subppulatins in Jrdan Valley. Althugh OPV3 cverage by 12 mnths f age was high amng Jrdanian children, cverage was lwer amng Pakistani, Beduin, and gypsy children. Delays in cmpleting OPV3 ccurred in all grups surveyed. Q! 6 ~ e ~ 4 infectins at the time OPV is administered [1-18]. At the time f the Jrdan utbreak, the sciecnmic status amng residents f the Jrdan Valley was generally cnsiderably lwer than in mst ther areas f Jrdan. Crwding and pr sanitatin, assciated with rapid spread f plivirus and ther enteric pathgens, were present in a number f areas in the Jrdan Valley. Furthermre, the Jrdan Valley is ne f nly tw areas in Jrdan with a subtrpical rather than an arid r temperate climate. Thus, many f the risk factrs fr subptimal immune respnse t OPV identified in ther settings were present in the Jrdan Valley at the time f the utbreak. The Jrdan utbreak was assciated with a 2-fld higher paralytic attack rate in the Jrdan Valley than in ther regins f the cuntry. Our investigatin findings suggest that at least three factrs-the presence f unimmunized subppulatins, delays in receipt f OPV, and lwer immune respnse t OPV in the Jrdan Valley cmpared with ther regins f the cuntry-likely cntributed t the high attack rate in that regin. In additin, the seasnal migratin fall three underimmunized subppulatins (Pakistanis, Beduins, and Gypsies) t the Jrdan Valley in the mnth prir t the utbreak may have been assciated with the initial intrductin and spread fwild plivirus in that regin. Furthermre, gegraphic and climatic factrs-a steep muntain range separating the Jrdan Valley frm ther areas f the cuntry and an unusually severe winter, with blizzards restricting travel t and frm the Jrdan Valley n three separate ccasins-likely played a rle in limiting the spread f wild plivirus during the utbreak. By cntrast, wild plivirus spread was mre limited and resulted in largely subclinical infectin in areas f the cuntry with high serprevalences fantibdies t pliviruses. In Safi,... 2 "' Age (mnths) Jrdanian Beduin Pakistani Gypsy a twn utside the Jrdan Valley where subptimal immune respnse t vaccine was als demnstrated, wild plivirus spread appeared t be mre extensive. Althugh the reasns fr largely subclinical infectin in mst areas utside the Jrdan Valley are unclear, ur findings suggest that high ppulatin serimmunity may have resulted in predminantly silent transmissin f wild plivirus utside the Jrdan Valley. A mass vaccinatin campaign limited t the Jrdan Valley and nearby areas during the third mnth f the utbreak did nt prevent wild plivirus spread t ther areas fthe cuntry. By cntrast, very few paralytic cases ccurred fllwing a natinwide mass vaccinatin campaign launched in the furth mnth f the utbreak, despite evidence that wild plivirus had already spread beynd the Jrdan Valley t ther areas f Jrdan. Since the natinwide campaign was launched late in the utbreak and at a time when cases had already begun t decline, its true impact is unclear. An alternative explanatin fr interruptin f wild plivirus transmissin during mnth f the Jrdan utbreak is that high preexisting serimmunity t infectin amng children in mst areas utside the Jrdan Valley limited the curse fthe utbreak. Thus, wild plivirus transmissin may have ceased as a result f exhaustin f the pl f susceptibles rather than as a result f the natinwide mass campaign. Gentypic studies prvide clear evidence that the utbreak strain was imprted [9, 1]. Clser hmlgy f the Jrdan strain with a Pakistan strain than with the Oman utbreak strain suggests that this represents a separate intrductin frm Pakistan rather than spread frm a fcus in the Middle East. Althugh a direct epidemilgic linkage culd nt be established, the gentypic findings, tgether with the ccurrence f Dwnladed frm by guest n 27 December 218

9 S7 Reichler et al. TID 1997;17 (Suppll) the first case in the utbreak amng Pakistani migrant wrkers, suggest that imprtatin may have ccurred directly int this cmmunity. In recent years, wild pliviruses imprted frm the India Pakistan subcntinent have been assciated with utbreaks in Oman [3], Malaysia [4], Netherlands [], and nw Jrdan. T prevent recurrent imprtatin, the best lng-term slutin is t eradicate wild plivirus reservirs in pli-endemic cuntries that are majr exprters f wild plivirus, including Pakistan and India. A nearly 8% reductin in reprted plimyelitis. cases in Pakistan fllwing natinal immunizatin days (NIDs) in 1994 [19, 2] and India's recent cmmitment t cnduct NIDs in 199 and 1996 prvide hpe that the risk f imprtatin will be reduced in the near future. The reintrductin and spread f wild plivirus in the Jrdan Valley and subsequently in ther areas f Jrdan demnstrates the imprtance fachieving high serimmunityt infectin in all gegraphic areas t prevent utbreaks caused by imprted strains f wild plivirus. Until glbal eradicatin f plimyelitis is accmplished, supplementing rutine immunizatin with mass campaign dses fopv-which are believed t be mre immungenic than OPV delivered thrugh the rutine prgram [21, 22]-and achieving high OPV cverage in all cmmunity subppulatins in a timely fashin may be effective means f ensuring unifrmly high ppulatin serimmunity t infectin. Acknwledgments Weare indebted t Atef Batyneh fr encuragement and supprt; Nadjwa Khuri-Buls fr assistance in evaluating suspected plimyelitis cases; Ali Assad, Bassam Hijawi, and physicians frm the Health Directrates in the Jrdan Valley fr assistance in cnducting fieldwrk fr the serepidemilgic studies; Snia Russell and Barbara Rice fr graphics assistance; and Peter Bing fr helpful cmments n the manuscript. References 1. Paul JR. A histry f plimyelitis. New Haven: Yale University Press, Strebel PM, Sutter RW, Cchi SL, et al. Epidemilgy f plimyelitis in the United States ne decade after the last reprted case f indigenus wild virus-assciated disease. Clin Infect Dis 1992; 14: SutterRW, PatriarcaPA, Brgan S, et al. Outbreakf paralytic plimyelitis in Oman. Evidence fr widespread transmissin amng fully vaccinated children. Lancet 1991;338: Centers fr Disease Cntrl and Preventin. Prgress tward glbal eradicatin f plimyelitis, MMWR 1994;43: Ostvgel PM, van WijngaardenJK, van der Avrt HG, et al. Plimyelitis utbreak in an unvaccinated cmmunity in the Netherlands, Lancet 1994;344: Hull HF, Ward NA, Hull BP, Milstien JB, de Quadrs C. Paralytic plimyelitis: seasned strategies, disappearing disease. Lancet 1994; 343: Melnick JL, Wenner HA, Phillips CA. Enterviruses. In: Lennette EH, Schmidt NJ, eds. Diagnstic prcedure fr viral, rickettsial, and chlamydial infectins. Washingtn DC: American Public Health Assciatin, 1979: Ric-Hesse R, Pallansch MA, Nttay BK, Kew OM. Gegraphic distributin f wild plivirus type 1 gentypes. Virlgy 1987; 16: Mulders MN, Lipskaya GY, van der Avrt HGAM, Kpmans MPG, Kew OM, van Ln AM. Mlecular epidemilgy f wild plivirus type 1 in Eurpe, the Middle East, and the Indian subcntinent. J Infect Dis 199;171: Huvilainen A, Mulders M, Agbatwalla M, Pyry T, Stenvik M, Hvi T. Genetic divergence f plivirus strains islated in the Karachi regin f Pakistan. J Gen Virl 1996; 76: Orenstein WA, Bernier RH, Dnder TJ, et al. Field evaluatin f vaccine efficacy. Bull WHO 198;63: Wrld Health Organizatin. Expanded Prgramme n Immunizatin. Plimyelitis utbreak, Bulgaria. Wkly Epidemil Rec 1992;67: Strebel P, Aubert-Cmiescu A, ln-nedelcu N, et al. Paralytic plimyelitis in Rmania, : evidence fr a high risk f vaccine assciated disease and reintrductin f wild-virus infectin. Am J Epidemil 1994; 14: Sutter RW, Patriarca PA, Suleiman AJ, et al. Paralytic plimyelitis in Oman: assciatin between reginal differences in attack rate and variatins in antibdy respnses t ral plivirus vaccine. lnt J Epidemil 1993; 22: Jhn TJ, Jayabal P. Oral plivirus vaccinatin in the trpics. The pr sercnversin rates and the absence fviral interference. Am J Epidemil 1972;96: Pangi NS, Master JM, Dave KH. Efficacy f ral pli vaccine in infancy. Indian Pediatr 1977; 14: Mahmud AA, Imam IZ, Abuzid SS, Mished AME, Mitkis FA. The influence f bacillary dysentery n the efficacy f ral plivaccine in Egypt. Gazette Egyptian Paediatr Assc 1976;24: Lebarn C, Linkins R, Glass R, et al. Reductin in the immungenicity f ral plivirus vaccine (OPV) fllwing rtavirus infectin: preliminary evidence frm Brazil [abstract]. In: Prgram and abstracts f the 34th Interscience Cnference n Antimicrbial Agents and Chemtherapy (Orland). Washingtn, DC: American Sciety fr Micrbilgy, 1991: Wahdan MH, Aslanian R, Reichler MR, Gaafar M. Prgress tward plimyelitis eradicatin in the Eastern Mediterranean Regin f the Wrld Health Organizatin. J Infect Dis 1997(suppl 1); 17:S-. 2. Reichler MR, Aslanian R, Ldhi ZH, et al. Evaluatin f ral plivirus vaccine delivery during the 1994 natinal immunizatin days in Pakistan. J Infect Dis 1997(suppl 1); 17:S Reichler MR, Kharabsheh S, Rhdes P, et al. Increased immungenicity f ral plivirus vaccine administered in mass vaccinatin campaigns cmpared with the rutine vaccinatin prgram in Jrdan. J Infect Dis 1997(suppl 1); 17:S Richardsn G, Linkins R, Eames M, et al. Immungenicity fral plivirus vaccine administered in mass campaigns versus rutine immunizatin prgrams. Bull Wrld Health Organ 199;73: Dwnladed frm by guest n 27 December 218

Response to. type 2 vaccine-derived polioviruses. prior to global topv withdrawal. Interim Guidelines

Response to. type 2 vaccine-derived polioviruses. prior to global topv withdrawal. Interim Guidelines Respnse t type 2 vaccine-derived pliviruses prir t glbal topv withdrawal Interim Guidelines August 2015 GPEI peratinal guidance nte August 2015 Summary Prepare fr prmpt actin fr any area r ppulatin at

More information

CDC Influenza Division Key Points MMWR Updates February 20, 2014

CDC Influenza Division Key Points MMWR Updates February 20, 2014 CDC Influenza Divisin Key Pints MMWR Updates In this dcument: Summary Key Messages Seasnal Influenza Vaccine Effectiveness: Interim Adjusted Estimates Influenza Surveillance Update: September 29, 2013-February

More information

Health Screening Record: Entry Level Due: August 1st MWF 150 Entry Year

Health Screening Record: Entry Level Due: August 1st MWF 150 Entry Year Health Screening Recrd: Entry Level MIDWIFERY EDUCATION PROGRAM HEALTH SCREENING REQUIREMENTS (Rev. June 2017) 1. Hepatitis B: Primary vaccinatin series (3 vaccines 0, 1 and 6 mnths apart), plus serlgic

More information

The estimator, X, is unbiased and, if one assumes that the variance of X7 is constant from week to week, then the variance of X7 is given by

The estimator, X, is unbiased and, if one assumes that the variance of X7 is constant from week to week, then the variance of X7 is given by ESTIMATION PROCEDURES USED TO PRODUCE WEEKLY FLU STATISTICS FROM THE HEALTH INTERVIEW SURVEY James T. Massey, Gail S. Pe, Walt R. Simmns Natinal Center fr Health Statistics. INTRODUCTION In April 97, the

More information

Howard E. Gary, Jr., Ray Sanders, and Mark A. Pallansch. Methods

Howard E. Gary, Jr., Ray Sanders, and Mark A. Pallansch. Methods S141 A Theretical Framewrk fr Evaluating the Sensitivity f Surveillance fr Detecting Wild Plivirus: II. Factrs Affecting Detectin Sensitivity in a Ppulatin with Circulating Wild Plivirus Hward E. Gary,

More information

This information shows what new challenges are likely to require prevention efforts moving forward.

This information shows what new challenges are likely to require prevention efforts moving forward. Release f CDC s Healthcare-Assciated Infectins (HAI) Pint Prevalence Survey and Annual Natinal and State HAI Prgress Reprt Embarged until: Wednesday, March 26 th at 12 nn ET Key Messages Overall These

More information

Chapter 6: Impact Indicators

Chapter 6: Impact Indicators Overview Chapter 6: Impact Indicatrs The best measure f the lng-term impact f all HIV preventin activities is the HIV incidence rate, namely the number f new cases f HIV infectin per year divided by the

More information

CDC Influenza Technical Key Points February 15, 2018

CDC Influenza Technical Key Points February 15, 2018 CDC Influenza Technical Key Pints In this dcument: Summary Key Pints U.S. Vaccine Effectiveness U.S. Flu Activity Update Summary Key Pints On Thursday, tw influenza-related reprts appeared in the Mrbidity

More information

Key Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red.

Key Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red. Key Pints Entervirus D68 in the United States, 2014 Nte: Newly added infrmatin is in red. Over the last several mnths, the United States has experienced a natinwide utbreak f entervirus D68 (EV- D68) assciated

More information

LTCH QUALITY REPORTING PROGRAM

LTCH QUALITY REPORTING PROGRAM 4 LTCH QUALITY REPORTING PROGRAM GENERAL INFORMATION...3 LTCH FACILITY-LEVEL QUALITY MEASURE REPORT...5 LTCH PATIENT-LEVEL QUALITY MEASURE REPORT...18 LTCH REVIEW AND CORRECT REPORT...23 09/2018 v1.04

More information

Implementation of G6PD testing and radical cure in P. vivax endemic countries: considerations

Implementation of G6PD testing and radical cure in P. vivax endemic countries: considerations Implementatin f G6PD testing and radical cure in P. vivax endemic cuntries: cnsideratins Malaria Plicy Advisry Cmmittee Geneva, Switzerland 16-18 September 2015 1 WHO Guidelines n Radical Cure WHO guidelines

More information

Key Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red.

Key Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red. Key Pints Entervirus D68 in the United States, 2014 Nte: Newly added infrmatin is in red. The United States is currently experiencing a natinwide utbreak f entervirus D68 (EV-D68) assciated with severe

More information

MANITOBA HEALTH, HEALTHY LIVING & SENIORS WEEKLY WEST NILE VIRUS SURVEILLANCE REPORT (WEEK 27)

MANITOBA HEALTH, HEALTHY LIVING & SENIORS WEEKLY WEST NILE VIRUS SURVEILLANCE REPORT (WEEK 27) MANITOBA HEALTH, HEALTHY LIVING & SENIORS WEEKLY WEST NILE VIRUS SURVEILLANCE REPORT (WEEK 27) The weekly West Nile Virus Surveillance Reprt utlines the mst current surveillance data and is psted weekly

More information

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data. abcd Clinical Study Synpsis fr Public Disclsure This clinical study synpsis is prvided in line with Behringer Ingelheim s Plicy n Transparency and Publicatin f Clinical Study Data. The synpsis which is

More information

CHAPTER 2. HEALTH SERVICES

CHAPTER 2. HEALTH SERVICES CHAPTER 2. HEALTH SERVICES 2.1 Treatment f substance use disrders within health services Thmas F Babr and Kerstin Stenius Overview Since the end f the Secnd Wrld War there has been a cnsistent grwth f

More information

The data refer to persons aged between 15 and 54.

The data refer to persons aged between 15 and 54. Drug-related hspital stays in Australia 1993-2005 Prepared by Amanda Rxburgh and Luisa Degenhardt, Natinal Drug and Alchl Research Centre Funded by the Australian Gvernment Department f Health and Ageing

More information

CDC Influenza Division Key Points November 7, 2014

CDC Influenza Division Key Points November 7, 2014 In this dcument: Summary Key Messages FluView Activity Update LAIV Effectiveness and Vaccinatin f Children H3N2 Match and Vaccinatin Vaccine Supply Summary Key Messages This week s FluView reprt indicates

More information

Safety of HPV vaccination: A FIGO STATEMENT

Safety of HPV vaccination: A FIGO STATEMENT FIGO Statement n HPV Vaccinatin Safety, August 2nd, 2013 Safety f HPV vaccinatin: A FIGO STATEMENT July, 2013 Human papillmavirus vaccines are used in many cuntries; glbally, mre than 175 millin dses have

More information

Tick fever is a cattle disease caused by any one of the following blood parasites:

Tick fever is a cattle disease caused by any one of the following blood parasites: Tick fever Tick fever is a cattle disease caused by any ne f the fllwing bld parasites: Babesia bvis Babesia bigemina Anaplasma marginale These parasites are all transmitted by the cattle tick (Bphilus

More information

Field Epidemiology Training Program

Field Epidemiology Training Program Field Epidemilgy Training Prgram Cancer Curriculum: Principles f Cancer Registries Case Study: Hspital-Based Cancer Registries FACILITATOR GUIDE FETP Cancer Curriculum: Principles f Cancer Registries Case

More information

Medical Student Immunization Requirements

Medical Student Immunization Requirements Medical Student Immunizatin Requirements The State f Illinis cde, Reference: (110 ILCS 20) Cllege Student Immunizatin Act, requires students t prvide prf f immunity: Measles (Rubela), Mumps, Rubella (German

More information

Risk factors in health and disease

Risk factors in health and disease Risk factrs in health and disease Index 1 Intrductin 2 Types f risk factrs 2.1 Behaviural risk factrs 2.2 Psychlgical risk factrs 2.3 Demgraphic risk factrs 2.4 Envirnmental risk factrs 2.5 Genetic risk

More information

Malaria 2025: Accelerate to Eliminate The Global Technical Strategy for Malaria: Setting global targets Azra Ghani, GTS Steering Committee

Malaria 2025: Accelerate to Eliminate The Global Technical Strategy for Malaria: Setting global targets Azra Ghani, GTS Steering Committee Malaria 2025: Accelerate t Eliminate The Glbal Technical Strategy fr Malaria: 2016-2025 Setting glbal targets Azra Ghani, GTS Steering Cmmittee Geneva, 12 March 2014 1 Visin and Gals Purpse f Visin and

More information

iprex Fact Sheet: Key Results

iprex Fact Sheet: Key Results EMBARGOED UNTIL RELEASE Tuesday, 23 Nvember 2010, 8 a.m. EST CONTACT Mark Aurigemma; 646-270-9451; mark@aucmm.net Pedr Gicchea; 415-490-8350 pgicchea@gladstne.ucsf.edu iprex Fact Sheet: Key Results iprex

More information

Guidance for Applicants to the Global fund to Fight AIDS, TB and Malaria Round 8 Call for proposals 28 February 2008

Guidance for Applicants to the Global fund to Fight AIDS, TB and Malaria Round 8 Call for proposals 28 February 2008 Guidance fr Applicants t the Glbal fund t Fight AIDS, TB and Malaria Rund 8 Call fr prpsals 28 February 2008 Sexual Minrities Backgrund: The bard f the Glbal Fund t Fight AIDS, TB and Malaria at its 16

More information

Hospital Preparedness Checklist

Hospital Preparedness Checklist Hspital Preparedness Checklist http://pandemicflu.gv Preparedness Subject 1. Structure fr planning and decisin making An internal, multidisciplinary planning cmmittee fr influenza preparedness has been

More information

23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline)

23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline) Intrductin & Aims Drug and Alchl Cnsultatin Liaisn (AOD CL) services aim t imprve identificatin and treatment f patients with AOD mrbidity. The csts and cnsequences f targeting AOD patients presenting

More information

H1N1 Influenza 09 Guidance for Residential Aged Care

H1N1 Influenza 09 Guidance for Residential Aged Care H1N1 Influenza 09 Guidance fr Residential Aged Care 11 June 2009 As knwledge abut H1N1 Influenza 09 develps, further advice will be prvided. Please check www.healthemergency.gv.au fr the latest infrmatin.

More information

Immunisation and Disease Prevention Policy

Immunisation and Disease Prevention Policy Immunisatin and Disease Preventin Plicy Quality Area 2: Children s Health and Safety 2.1 Each child s health is prmted 2.1.4 Steps are taken t cntrl the spread f infectius diseases and t manage injuries

More information

CDC Influenza Division Key Points December 9, 2016

CDC Influenza Division Key Points December 9, 2016 In this dcument: Summary Key Pints Summary f Influenza Virus Labratry Data FluView Activity Update Early Influenza Vaccine Cverage Estimates fr 2016-17 Influenza Vaccine Prgram Impact Estimates fr 2015-16

More information

Lyme Disease Surveillance in North Carolina

Lyme Disease Surveillance in North Carolina Lyme Disease Surveillance in Nrth Carlina 2008-2014 Carl Williams DVM Megan Sanza MPH Cmmunicable Disease Branch Divisin f Nrth Carlina Public Health Lyme Disease Surveillance in Nrth Carlina 2008-2014

More information

Campus Climate Survey

Campus Climate Survey Campus Climate Survey Executive Summary www.ecu.edu/ecyu 2016 A prject spnsred by the Office fr Equity and Diversity Executive Summary Prject Backgrund In FY 2013-2014, the Campus Climate Cmmissin prpsed

More information

US Public Health Service Clinical Practice Guidelines for PrEP

US Public Health Service Clinical Practice Guidelines for PrEP Webcast 1.3 US Public Health Service Clinical Practice Guidelines fr PrEP P R E S ENTED BY: M A R K T H R U N, M D A S S O C I AT E P R O F E S S O R, U N I V E R S I T Y O F C O L O R A D O, D I V I S

More information

Pediatric and adolescent preventive care and HEDIS *

Pediatric and adolescent preventive care and HEDIS * Pediatric and adlescent preventive care and HEDIS * * HEDIS is a registered trademark f the Natinal Cmmittee fr Quality Assurance (NCQA). UniCare Health Plan f West Virginia, Inc. Healthcare Effectiveness

More information

UNIT 2: mapping bananas

UNIT 2: mapping bananas Oxfam Educatin www.xfam.rg.uk/educatin UNIT 2: mapping bananas Age range: 7-11 years Outline Learners will investigate sme f the cuntries where the bananas we eat in the UK are grwn. They will first lcate

More information

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland AWARD NUMBER: W81XWH-14-1-0444 TITLE: Culd HER2 Hetergeneity Open New Therapeutic Optins in Patients with HER2- Primary Breast Cancer? PRINCIPAL INVESTIGATOR: Gary Ulaner, MD, PhD CONTRACTING ORGANIZATION:

More information

Public consultation on the NHMRC s draft revised Australian alcohol guidelines for low-risk drinking

Public consultation on the NHMRC s draft revised Australian alcohol guidelines for low-risk drinking Public cnsultatin n the NHMRC s draft revised Australian alchl guidelines fr lw-risk drinking Recmmendatins frm The Cancer Cuncil Australia The Cancer Cuncil Australia is Australia s peak nn-gvernment

More information

SUICIDE AND MENTAL ILLNESS IN SINGAPORE

SUICIDE AND MENTAL ILLNESS IN SINGAPORE Vl. 15, N. 3. SINGAPORE MEDICAL JOURNAL 191 September, 1974. SUICIDE AND MENTAL ILLNESS IN SINGAPORE By W. F. Tsi and B. H. Chia SYNOPSIS This is a study f 112 cases f suicides wh had a past histry f being

More information

The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only.

The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only. The clinical trial infrmatin prvided in this public disclsure synpsis is supplied fr infrmatinal purpses nly. Please nte that the results reprted in any single trial may nt reflect the verall ptential

More information

CSHCN Services Program Benefits to Change for Outpatient Behavioral Health Services Information posted November 10, 2009

CSHCN Services Program Benefits to Change for Outpatient Behavioral Health Services Information posted November 10, 2009 CSHCN Services Prgram Benefits t Change fr Outpatient Behaviral Health Services Infrmatin psted Nvember 10, 2009 Effective fr dates f service n r after January 1, 2010, benefit criteria fr utpatient behaviral

More information

CFS Private Sector modalities

CFS Private Sector modalities CFS Private Sectr mdalities APPROVED September 8, 2011 A. BACKGROUND 1. Fd security exists when all peple at all times have physical and ecnmic access t sufficient, safe and nutritius fd t meet their dietary

More information

Vaccine Information Statement: PNEUMOCOCCAL CONJUGATE VACCINE

Vaccine Information Statement: PNEUMOCOCCAL CONJUGATE VACCINE Vaccine Infrmatin Statement: PNEUMOCOCCAL CONJUGATE VACCINE Many Vaccine Infrmatin Statements are available in Spanish and ther languages. See www.immunize.rg/vis. Hjas de Infrmacián Sbre Vacunas están

More information

2017 CMS Web Interface

2017 CMS Web Interface CMS Web Interface PREV-5 (NQF 2372): Breast Cancer Screening Measure Steward: NCQA Web Interface V1.0 Page 1 f 18 11/15/2016 Cntents INTRODUCTION... 3 WEB INTERFACE SAMPLING INFORMATION... 4 BENEFICIARY

More information

HPV VACCINATION IN SANDYFORD SERVICES

HPV VACCINATION IN SANDYFORD SERVICES HPV VACCINATION IN SANDYFORD SERVICES 1. General infrmatin n HPV Vaccinatin 2. HPV vaccinatin in females 3. Yung Wmen Only 4. HPV vaccinatin in MSM 1. General infrmatin General Infrmatin fr clinicians

More information

Appendix C. Master of Public Health. Practicum Guidelines

Appendix C. Master of Public Health. Practicum Guidelines Appendix C Master f Public Health Practicum Guidelines 0 Gergia State University, Schl f Public Health Master f Public Health Practicum Guidelines Fr mre infrmatin, cntact Jessica Hwell Pratt, MPH Practicum

More information

WCPT awards programme 2015

WCPT awards programme 2015 WCPT awards prgramme 2015 The WCPT awards prgramme recgnises utstanding cntributins and leadership by individual physical therapists and grups t the prfessin and/r glbal health at an internatinal level.

More information

DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 2016 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS

DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 2016 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 216 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS This briefing has been specifically prepared fr the Ministry f Health t prvide infrmatin frm this

More information

LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST

LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST OPTUM LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY / APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED

More information

GUIDANCE DOCUMENT FOR ENROLLING SUBJECTS WHO DO NOT SPEAK ENGLISH

GUIDANCE DOCUMENT FOR ENROLLING SUBJECTS WHO DO NOT SPEAK ENGLISH GUIDANCE DOCUMENT FOR ENROLLING SUBJECTS WHO DO NOT SPEAK ENGLISH Aurra Health Care s Research Subject Prtectin Prgram (RSPP) This guidance dcument will utline the prper prcedures fr btaining and dcumenting

More information

April 23, 2008 Information Sheet: Safety of BPA-derived Can Liners. Summary

April 23, 2008 Information Sheet: Safety of BPA-derived Can Liners. Summary April 23, 2008 Infrmatin Sheet: Safety f BPA-derived Can Liners Summary The use f bisphenl A (BPA)-derived epxy resins t make prtective catings fr metal fd and beverage packaging helps prvide safe, whlesme

More information

Athabasca Health Authority Keewatin Yatthé Health Region Mamawetan Churchill River Health Region

Athabasca Health Authority Keewatin Yatthé Health Region Mamawetan Churchill River Health Region Athabasca Health Authrity Keewatin Yatthé Health Regin Mamawetan Churchill River Health Regin Nrthern Saskatchewan Health Indicatrs Reprt 2011 Summary Athabasca Health Authrity Keewatin Yatthé Health Regin

More information

2018 Medical Association Poster Symposium Guidelines

2018 Medical Association Poster Symposium Guidelines 2018 Medical Assciatin Pster Sympsium Guidelines Overview The 3 rd Annual student-run Medical Assciatin f the State f Alabama Research Sympsium will take place n Friday and Saturday, April 13-14 at the

More information

Human papillomavirus (HPV) refers to a group of more than 150 related viruses.

Human papillomavirus (HPV) refers to a group of more than 150 related viruses. HUMAN PAPILLOMAVIRUS This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice r discussin between

More information

Patterns of Cholesterol Distribution in the Participants of a Screening Project

Patterns of Cholesterol Distribution in the Participants of a Screening Project Patterns f Chlesterl Distributin in the Participants f a Screening Prject Abdul Hamid Shaikh, S With guidelines similar t thse recmmended by the Natinal Chlesterl Educatin Prgram (NCEP), 3,3 individuals

More information

Pennsylvania Guidelines on the Use of Opioids to Treat Chronic Noncancer Pain

Pennsylvania Guidelines on the Use of Opioids to Treat Chronic Noncancer Pain Pennsylvania Guidelines n the Use f Opiids t Treat Chrnic Nncancer Pain Chrnic pain is a majr health prblem in the United States, ccurring with a pintprevalence f abut ne-third f the US ppulatin.(1) Mre

More information

CONTACT: Amber Hamilton TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW

CONTACT: Amber Hamilton TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW FACT SHEET CONTACT: Amber Hamiltn 212-266-0062 TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW Type 2 diabetes accunts fr 90-95% f the 29.1 millin diabetes cases in the U.S. 1 Obesity is a majr independent

More information

A Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma NANT (01-03) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol.

A Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma NANT (01-03) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol. SAMPLE INFORMED CONSENT A Phase I Study f CEP-701 in Patients with Refractry Neurblastma NANT (01-03) A New Appraches t Neurblastma Therapy (NANT) treatment prtcl. The wrd yu used thrughut this dcument

More information

Cancer Association of South Africa (CANSA)

Cancer Association of South Africa (CANSA) Cancer Assciatin f Suth Africa (CANSA) Fact Sheet and Psitin Statement n Cannabis in Suth Africa Intrductin Cannabis is a drug that cmes frm Indian hemp plants such as Cannabis sativa and Cannabis indica.

More information

Vaccine Information Statement: LIVE INTRANASAL INFLUENZA VACCINE

Vaccine Information Statement: LIVE INTRANASAL INFLUENZA VACCINE Vaccine Infrmatin Statement: LIVE INTRANASAL INFLUENZA VACCINE Many Vaccine Infrmatin Statements are available in Spanish and ther languages. See www.immunize.rg/vis. Hjas de Infrmacián Sbre Vacunas están

More information

77 WHO/IPA workshop on Immunisation

77 WHO/IPA workshop on Immunisation 77 WHO/IPA wrkshp n Immunisatin cst/efficacy f either f them des nt justify their rutine use. Cntents f such diseases shuld be within the respnsibilities f the Epidemilgy Department. XVII INTERNATIONAL

More information

Iowa Early Periodic Screening, Diagnosis and Treatment Care for Kids Program Provider Training

Iowa Early Periodic Screening, Diagnosis and Treatment Care for Kids Program Provider Training Iwa Early Peridic Screening, Diagnsis and Treatment Care fr Kids Prgram Prvider Training The Early Peridic Screening, Diagnsis and Treatment (EPSDT) Care fr Kids prgram is Iwa s Medicaid prgram fr children.

More information

Eye on Influenza. o Available Vaccine Products and Indications: See

Eye on Influenza. o Available Vaccine Products and Indications: See Archived Dcument Archive Disclaimer: The fllwing Health Care Agency dcument is fr histrical purpses nly. The infrmatin prvided was accurate at the time it was riginally presented. The Health Care Agency

More information

What You Need to Know About ZIKA VIRUS

What You Need to Know About ZIKA VIRUS What Yu Need t Knw Abut ZIKA VIRUS Refugee and Immigrant Health Seminar Tuesday, Nvember 1, 2016 Malaya Fletcher, MPH Glbal Migratin & Mnitring Crdinatr PDPH Divisin f Disease Cntrl 1 Backgrund n Zika

More information

STUDIES WITH HUMAN INFLUENZA VIRUS CULTIVATED IN ARTIFICIAL MEDIUM

STUDIES WITH HUMAN INFLUENZA VIRUS CULTIVATED IN ARTIFICIAL MEDIUM Published Online: 1 June, 1936 Supp Inf: http://di.rg/1.184/jem.63.6.83 Dwnladed frm jem.rupress.rg n August 13, 218 STUDIES WITH HUMAN INFLUENZA VIRUS CULTIVATED IN ARTIFICIAL MEDIUM BY T. P. MAGILL,

More information

Podcast Transcript Title: Common Miscoding of LARC Services Impacting Revenue Speaker Name: Ann Finn Duration: 00:16:10

Podcast Transcript Title: Common Miscoding of LARC Services Impacting Revenue Speaker Name: Ann Finn Duration: 00:16:10 Pdcast Transcript Title: Cmmn Miscding f LARC Services Impacting Revenue Speaker Name: Ann Finn Duratin: 00:16:10 NCTCFP: Welcme t this pdcast spnsred by the Natinal Clinical Training Center fr Family

More information

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION INSTRUCTIONS This is an infrmed cnsent dcument which has been prepared t help yur Dctr infrm yu cncerning fat reductin with an injectable medicatin, its risks,

More information

Improving Surveillance and Monitoring of Self-harm in Irish Prisons

Improving Surveillance and Monitoring of Self-harm in Irish Prisons HSE Mental Health Divisin Stewart s Hspital, Palmerstwn, Dublin 20 Tel: 01 6201670 Email: inf@nsp.ie www.nsp.ie Imprving Surveillance and Mnitring f Self-harm in Irish Prisns Prject Scpe Dcument 8 th June

More information

Frequently Asked Questions: IS RT-Q-PCR Testing

Frequently Asked Questions: IS RT-Q-PCR Testing Questins 1. What is chrnic myelid leukemia (CML)? 2. Hw des smene knw if they have CML? 3. Hw is smene diagnsed with CML? Frequently Asked Questins: IS RT-Q-PCR Testing Answers CML is a cancer f the bld

More information

President Chirac understood that fighting disease is not just health systems and hospitals, it is about people. We must place people at the centre.

President Chirac understood that fighting disease is not just health systems and hospitals, it is about people. We must place people at the centre. Michel Sidibé Executive Directr, UNAIDS Speech Opening Ceremny 2016 Wrld Cancer Cngress 31 st Octber 2016, Paris, France Cngratulatins and grateful thanks t the rganizers - Unin fr Internatinal Cancer

More information

IRAQ: Early Warning and Disease Surveillance Bulletin

IRAQ: Early Warning and Disease Surveillance Bulletin EWARN EARLY WARNING AND RESPONSE NETWORK IRAQ: Early Warning and Disease Surveillance Bulletin Epidemilgical Week 14: Reprting Perid: 30 March 5 April 2015 Overview During week 14, twenty ne reprting sites

More information

Related Policies None

Related Policies None Medical Plicy MP 3.01.501 Guidelines fr Cverage f Mental and Behaviral Health Services Last Review: 8/30/2017 Effective Date: 8/30/2017 Sectin: Mental Health End Date: 08/19/2018 Related Plicies Nne DISCLAIMER

More information

Breast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018)

Breast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018) Breast Cancer Awareness Mnth 2018 Key Messages (as f June 6, 2018) In this dcument there are tw sectins f messages in supprt f Cancer Care Ontari s Breast Cancer Awareness Mnth 2018: 1. Campaign key messages

More information

M.R.C.Path. causes to the raised plasma urea in patients admitted

M.R.C.Path. causes to the raised plasma urea in patients admitted Pstgradcuate Medical Jurnal (January 1979) 55, 1-14 The cause f the raised plasma urea f acute heart failure R D THOMAS MRCP D B MORGAN MRCPath ALISON NWILL AIMLS Departments f Cardilgy and Chemical Pathlgy,

More information

TOP TIPS Lung Cancer Update Dr Andrew Wight Consultant respiratory Physician - WUTH

TOP TIPS Lung Cancer Update Dr Andrew Wight Consultant respiratory Physician - WUTH Tpic Circulatin list In case f query please cntact Executive Summary TOP TIPS Lung Cancer Update Dr Andrew Wight Cnsultant respiratry Physician - WUTH All Wirral GP s JaneFletcher2@nhs.net Dear Clleagues,

More information

2017 CMS Web Interface

2017 CMS Web Interface CMS Web Interface CARE-2 (NQF 0101): Falls: Screening fr Future Fall Risk Measure Steward: NCQA Web Interface V1.0 Page 1 f 18 11/15/2016 Cntents INTRODUCTION... 3 WEB INTERFACE SAMPLING INFORMATION...

More information

A fake medicine that passes itself off as a real, authorised medicine. (1)

A fake medicine that passes itself off as a real, authorised medicine. (1) Falsified medicines Index 1 Intrductin 2 Types f falsified medicines 3 Eurpean regulatin n falsified medicines 4 Risks f falsified medicines 5 Buying medicine nline safely 6 References 7 Further resurces

More information

Q 5: Is relaxation training better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder?

Q 5: Is relaxation training better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder? updated 2012 Relaxatin training Q 5: Is relaxatin training better (mre effective than/as safe as) than treatment as usual in adults with depressive episde/disrder? Backgrund The number f general health

More information

Pandemic H1N1 2009: DrillSafe Update. David Blizzard BD Manager, Energy Mining and Infrastructure

Pandemic H1N1 2009: DrillSafe Update. David Blizzard BD Manager, Energy Mining and Infrastructure Pandemic H1N1 2009: DrillSafe Update David Blizzard BD Manager, Energy Mining and Infrastructure Pandemic H1N1 Update CDC.Gv USA Pandemic H1N1 Summary Pints Virus cntinues t spread with nearly all WHO

More information

A pre-conference should include the following: an introduction, a discussion based on the review of lesson materials, and a summary of next steps.

A pre-conference should include the following: an introduction, a discussion based on the review of lesson materials, and a summary of next steps. NAU Mdel Observatin Prtcl The mdel prtcl was develped with supprt and expertise frm the Natinal Institute fr Excellence in Teaching (NIET) and is based in great part n NIET s extensive experience cnducting

More information

Reliability and Validity Plan 2017

Reliability and Validity Plan 2017 Reliability and Validity Plan 2017 Frm CAEP The principles fr measures used in the CAEP accreditatin prcess include: (a) validity and reliability, (b) relevance, (c) verifiability, (d) representativeness,

More information

The principles of evidence-based medicine

The principles of evidence-based medicine The principles f evidence-based medicine By the end f this mdule yu shuld be able t: Describe what evidence based medicine is Knw where t find quality evidenced based medicine n the internet Be able t

More information

c. J. Peters,* R. H. PureeD, J. J. Lander, t and K. M. Johnson

c. J. Peters,* R. H. PureeD, J. J. Lander, t and K. M. Johnson THE JOURNAL OF INFECTIOUS DISEASES VOL. 134, NO.3 SEPTEMBER 1976 1976 by the University f Chicag. All rights reserved. Radiimmunassay fr Antibdy t Hepatitis B Surface Antigen Shws Transmissin f Hepatitis

More information

Cardiac Rehabilitation Services

Cardiac Rehabilitation Services Dcumentatin Guidance N. DG1011 Cardiac Rehabilitatin Services Revisin Letter A 1.0 Purpse The Centers fr Medicare and Medicaid Services (CMS) has detailed specific dcumentatin requirements fr Cardiac Rehabilitatin

More information

Osteoporosis Fast Facts

Osteoporosis Fast Facts Osteprsis Fast Facts Fast Facts n Osteprsis Definitin Osteprsis, r prus bne, is a disease characterized by lw bne mass and structural deteriratin f bne tissue, leading t bne fragility and an increased

More information

Reference: Patient A. Brenda WXXXXX Date of Birth: 4/15/57

Reference: Patient A. Brenda WXXXXX Date of Birth: 4/15/57 Reference: Patient A Brenda WXXXXX Date f Birth: 4/15/57 49 year ld white female patient presented n July 20, 2006 with chief cmplaint f stage 4 cancer, initially diagnsed in Octber, 2003 with Cervical

More information

FDA Dietary Supplement cgmp

FDA Dietary Supplement cgmp FDA Dietary Supplement cgmp FEBRUARY 2009 OVERVIEW Summary The Fd and Drug Administratin (FDA) has issued a final rule regarding current gd manufacturing practices (cgmp) fr dietary supplements that establishes

More information

Assessment Field Activity Collaborative Assessment, Planning, and Support: Safety and Risk in Teams

Assessment Field Activity Collaborative Assessment, Planning, and Support: Safety and Risk in Teams Assessment Field Activity Cllabrative Assessment, Planning, and Supprt: Safety and Risk in Teams OBSERVATION Identify a case fr which a team meeting t discuss safety and/r safety planning is needed r scheduled.

More information

2017 Optum, Inc. All rights reserved BH1124_112017

2017 Optum, Inc. All rights reserved BH1124_112017 1) What are the benefits t clients f encuraging the use f MAT? Withut MAT, 90% f individuals with Opiid Use Disrder (OUD) will relapse within ne year. With MAT, the relapse rate fr thse with OUD decreases

More information

Dear University of Chicago Student,

Dear University of Chicago Student, Dear University f Chicag Student, The state f Illinis and the University f Chicag require students t have prf f immunity fr certain diseases including Measles (Rubela), Mumps, Rubella (German Measles)

More information

HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING. Public Health Relevance. Highlights.

HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING. Public Health Relevance. Highlights. HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING Public Health Relevance Cervical cancer is 90% preventable by having regular Papaniclau (Pap) tests. The Pap test, als knwn as a cervical smear,

More information

Epidemic Planet. Interactively visualizing and comparing epidemic simulations.

Epidemic Planet. Interactively visualizing and comparing epidemic simulations. Epidemic Planet Interactively visualizing and cmparing epidemic simulatins. Exhibit descriptin - summary Title f the exhibitin: Epidemic Planet Abstract A better understanding and mre accurate frecasting

More information

Rush Copley Medical Center 2017 Prevention and Screening Initiatives

Rush Copley Medical Center 2017 Prevention and Screening Initiatives Cmmunity Needs Assessment Rush Cpley Medical Center 2017 Preventin and Screening Initiatives Rush Cpley Medical Center s (RCMC) main service areas include Kane Cunty and Kendall Cunty, Illinis. The 2014

More information

Zika Virus. Where has Zika virus been found? Zika in the United States and its territories:

Zika Virus. Where has Zika virus been found? Zika in the United States and its territories: Where has Zika virus been fund? Zika Virus Prir t 2015, Zika virus utbreaks have ccurred in areas f Africa, Sutheast Asia, and the Pacific Islands. In May 2015, the Pan American Health Organizatin (PAHO)

More information

Health action in crisis

Health action in crisis Health actin in crisis WHO Emergency Health Prgramme fr the Fd Crisis in Niger Situatin Reprt # 10 11 t 17 Octber 2005 Highlights Training f healthcare trainers and healthcare wrkers n the treatment f

More information

STAKEHOLDER IN-DEPTH INTERVIEW GUIDE

STAKEHOLDER IN-DEPTH INTERVIEW GUIDE STAKEHOLDER IN-DEPTH INTERVIEW GUIDE PURPOSE The Stakehlder In-Depth Interview Guide cntributes t understanding the scale-up prcess by asking key stakehlders t evaluate what has been achieved in scaleup,

More information

Service Change Process. Gateway 1 High-level Proposition. Innovation project name: Patient Self-Monitoring/Management of Warfarin

Service Change Process. Gateway 1 High-level Proposition. Innovation project name: Patient Self-Monitoring/Management of Warfarin Service Change Prcess Gateway 1 High-level Prpsitin Innvatin prject name: Patient Self-Mnitring/Management f Warfarin NHS Bury Please describe the service change being prpsed. Please describe what service(s)

More information

Swindon Joint Strategic Needs Assessment Bulletin

Swindon Joint Strategic Needs Assessment Bulletin Swindn Jint Strategic Needs Assessment Bulletin Swindn Diabetes 2017 Key Pints: This JSNA gives health facts abut peple with diabetes r peple wh might get diabetes in Swindn. This helps us t plan fr medical

More information

Dear Student, IMMUNIZATION RECORD INSTRUCTIONS

Dear Student, IMMUNIZATION RECORD INSTRUCTIONS Dear Student, Welcme t the University f Chicag! The State f Illinis and University regulatins require students t prvide prf f required immunizatins prir t registratin fr classes. In rder t cmplete this

More information

M.J. Guthriel, D.G. Wagner2

M.J. Guthriel, D.G. Wagner2 EFFECT OF SUPPLEMENTAL PROTEIN OR GRAIN ON INTAKE AND UTILIZATION OF MEDIUM QUALITY PRAIRIE HAY BY STEERS M.J. Guthriel, D.G. Wagner2 and D.C. Weakley3 Stry in Brief Sixteen 1,053 lb tw-year-ld Herefrd

More information

A. Catalonia World Health Organization Demonstration Project

A. Catalonia World Health Organization Demonstration Project A. Catalnia Wrld Health Organizatin Demnstratin Prject In 1989, the Health Department f Catalnia (Spain) and the Cancer Unit at the WHO (Geneva) designed and planned a demnstratin prject fr implementatin

More information